Tree analysis of mass spectral urine profiles discriminates transitional cell carcinoma of the bladder from noncancer patient

Clinical Biochemistry

Volumn 37, Issue 9, 2004, Pages 772-779

  Zhang, Yuan Fang ^a   Wu, Deng Long ^b   Guan, Ming ^a   Liu, Wei Wei ^a   Wu, Zhong ^a   Chen, Yu Ming ^a   Zhang, Wan Zhong ^a   Lu, Yuan ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Biomarker; Decision tree; Mass spectrometry; Surface enhanced laser desorption ionization (SELDI); Transitional cell carcinoma

Indexed keywords

ADULT; AGED; ALGORITHM; ARTICLE; BLADDER CARCINOMA; CLUSTER ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISCRIMINANT ANALYSIS; HUMAN; IONIZATION; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEOMICS; SENSITIVITY AND SPECIFICITY; TRANSITIONAL CELL CARCINOMA; URINALYSIS; UROGENITAL TRACT DISEASE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; DECISION TREES; HUMANS; MIDDLE AGED; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; URINARY BLADDER NEOPLASMS;

EID: 4344710503     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2004.04.002     Document Type: Article

References (23)

1. Jaemal A., Thomas A., Murray T., et al. Cancer statistics 2002. CA-Cancer J. Clin. 52:2002;23-47
2. Rubben H., Lutzeyer W., Fischer N., Deutz F., Lagrange W., Giani G. Natural history and treatment of low and high risk superficial bladder tumors. J. Urol. 139:1988;283-285
3. Fair W.R., Fuks Z.Y., Scher H.I. Cancer of the bladder. Devita V.T., Hellman S., Rosenberg S.A. Cancer. fourth ed. Princ. Pract. Oncol. vol. 1:1993;1056-1069 Lippincott, Philadelphia
4. Konety B.R., Getzenberg R.H. Urine based markers of urological malignancy. J. Urol. 165:2001;600-611
5. Cajulis R.S., Haines G.K., Frias-Hidvegi D., McVary K., Bacus J.W. Cytology, flow cytometry, image analysis, and interphase cytogenetics by fluorescence in situ hybridization in the diagnosis of transitional cell carcinoma in bladder washes: a comparative study. Diagn. Cytopathol. 13:1995;214-223
6. Sarosdy M.F., deVere R.W., White M.S., et al. Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer. J. Urol. 154(2 Pt. 1):1995;379-383
7. Stampfer D.S., Carpinito G.A., Rodriguez-Villanueva J., et al. Evaluation of NMP22 in the detection of transitional cell carcinoma of the bladder. J. Urol. 159:1998;394-398
8. Ferrari L., Seraglia R., Rossi C.R., et al. Protein profiles in sera of patients with malignant cutaneous melanoma. Rapid Commun. Mass Spectrom. 14:2000;1149-1154
9. Keough T., Lacey M.P., Fieno A.M., et al. Tandem mass spectrometry methods for definitive protein identification in proteomics research. Electrophoresis. 21:2000;2252-2265
10. Merchant M., Weinberger S.R. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis. 21:2000;1164-1177
11. Kuwata H., Yip T.T., Yip C.L., Tomita M., Hutchens T.W. Bactericidal domain of lactoferrin: detection, quantitation, and characterization of lactoferricin in serum by SELDI affinity mass spectrometry. Biochem. Biophys. Res. Commun. 245:1998;764-773
12. von Eggeling F., Junker K., Fiedle W., et al. Mass spectrometry meets chip technology: a new proteomic tool in cancer research? Electrophoresis. 22:2001;2898-2902
13. Paweletz C.P., Gillespie J.W., Ornstein D.K., et al. Rapid protein display profiling of cancer progression directly from human tissue using a protein biochip. Drug Dev. Res. 49:2000;34-42
14. Wellmann A., Wollscheid V., Lu H., et al. Analysis of microdissected prostate tissue with ProteinChip arrays - A way to new insights into carcinogenesis and to diagnostic tools. Int. J. Mol. Med. 9:2002;341-347
15. Cazares L.H., Adam B.L., Ward M.D., et al. Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry. Clin. Cancer Res. 8:2002;2541-2552
16. Wright G.L. Jr., Cazares L.H., Leung S.M., et al. Proteinchip surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures. Prostate Cancer Prostatic Dis. 2:1999;264-276
17. Xiao Z., Adam B.L., Cazares L.H., et al. Quantitation of serum prostate-specific membrane antigen by a novel protein biochip immunoassay discriminates benign from malignant prostate disease. Cancer Res. 61:2001;6029-6033
18. Banez L.L., Prasanna P., Sun L., et al. Diagnostic potential of serum proteomic patterns in prostate cancer. J. Urol. 170:2003;442-446
19. Rosty C., Christa L., Kuzdzal S., et al. Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology. Cancer Res. 62:2002;1868-1875
20. Anderson N.G., Anderson N.L., Tollaksen S.L. Proteins of human urine: I. Concentration and analysis by two-dimensional electrophoresis. Clin. Chem. 25:1979;1199-1210
21. Vlahou A., Schellhammer P.F., Mendrinos S., Patel K., Kondylis F.I., Gong L., et al. Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. Am. J. Pathol. 158:2001;1491-1502
22. Petricoin E.F., Ardekani A.M., Hitt B.A., et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet. 359:2002;572-577
23. Adam B.L., Qu Y., Davis J.W., et al. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res. 62:2002;3609-3614